small scotoma using Head Mounted Display No re-mapping for Age-related Macular Degeneration

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Age-related Macular DegenerationLarge scotoma using Head Mounted Display PLUS re-mapping - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial assesses a device that uses eye trackers and real-time image processing to help people with central vision loss.

Eligible Conditions
  • Age-related Macular Degeneration

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 5 years

5 years
Reading speed

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

small scotoma using Head Mounted Display No re-mapping
1 of 2
Large scotoma using Head Mounted Display PLUS re-mapping
1 of 2

Active Control

70 Total Participants · 2 Treatment Groups

Primary Treatment: small scotoma using Head Mounted Display No re-mapping · No Placebo Group · N/A

small scotoma using Head Mounted Display No re-mappingActiveComparator Group · 2 Interventions: Large scotoma using Head Mounted Display PLUS re-mapping, small scotoma using Head Mounted Display No re-mapping · Intervention Types: Other, Other
Large scotoma using Head Mounted Display PLUS re-mappingActiveComparator Group · 2 Interventions: Large scotoma using Head Mounted Display PLUS re-mapping, small scotoma using Head Mounted Display No re-mapping · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,256 Previous Clinical Trials
1,483,852 Total Patients Enrolled
1 Trials studying Age-related Macular Degeneration
108 Patients Enrolled for Age-related Macular Degeneration
Erik van Kuijk, MD, PhDPrincipal InvestigatorUniversity of Minnesota

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have no cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
You must be at least 18 years old.